Quantcast

PMD Healthcare Announces Support for Actions that People with Asthma or COPD Should Take to Prevent the Flu

February 21, 2013

Spiro PD Personal Spirometer supports four of the five critical steps to prevent flu transmission as the epidemic continues to affect people nationwide, particularly those with chronic lung conditions. For more information, visit http://www.SpiroPD.com.

Allentown, PA (PRWEB) February 21, 2013

Many healthcare professionals consider the current flu epidemic the worst in years. It has posed a severe threat to people with chronic lung conditions like asthma and COPD who are particularly vulnerable to the virus.

However, healthcare professionals now agree that five critical actions can help prevent flu transmission: monitoring breathing, reporting any changes in lung health to the doctor, staying on track with prescribed medications, getting a flu vaccine, and washing hands thoroughly.

As the world´s first personal spirometer, Spiro PD supports four of these five critical steps to prevent flu transmission.

Spiro PD empowers people with respiratory conditions to easily and accurately monitor their breathing any time and anywhere: at home, work, school, play, or while traveling.

Spiro PD lets patients quickly and simply upload their lung health data and share it with their doctor. So, if necessary, the doctor can easily make changes to the patient´s treatment in a timely manner.

Spiro PD enhances medication adherence by letting patients set alarms reminding them when to take their medicine, plus when to test their lung function and do breathing exercises.

The US Preventive Services Task Force (USPTF) has stated that evidence suggests influenza vaccination reduces COPD exacerbations. The USPTF, for a number of years, also has theorized that spirometry may help increase flu vaccination rates among people with COPD, asthma, emphysema, cystic fibrosis, or a lung transplant by helping them closely monitor their lung health.

Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, the maker of Spiro PD, says, “It is important that people with chronic respiratory conditions do everything they can to fight the flu. Spiro PD gives people with COPD, asthma, and other breathing conditions new power in their fight.”

In the United States, the cold and flu season is considered October through May, usually peaking in February.(1,2) Each year, colds and flu usually account for 200,000 hospitalizations and 41,000 deaths in this country.(3) People with respiratory conditions, including asthma, COPD, bronchitis, emphysema, cystic fibrosis, and a lung transplant, are particularly susceptible, and can develop life-threatening complications including pneumonias and acute respiratory distress syndrome.(4)

For more information about all the advantages that the Spiro PD Personal Spirometer offers people with respiratory conditions, please visit http://www.SpiroPD.com.

About Spiro PD

“Spiro” stands for spirometer, a device used to measure air entering and leaving the lungs; “PD” stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases — COPD, asthma, CF, and lung transplants — to easily and accurately monitor their breathing anytime and anywhere.

Spiro PD tracks lung function trends to help patients anticipate and prevent respiratory disease exacerbations, which helps reduce expensive emergency room visits and hospital stays. According to a study conducted at Johns Hopkins University, home spirometry detected decreased lung function 16 days before patients felt symptoms and sought medical care.(5)

Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.

Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.

Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Many insurance companies cover the cost of Spiro PD.

Spiro PD meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. Spiro PD is also certified with the CE mark for the European Union (EU).

For more information, visit http://www.SpiroPD.com.

About PMD Healthcare, Inc.

PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.

1. CDC Questions and Answers 2010-01-27, Retrieved 2010-08-10.

2. CDC: The Flu Season. http://www.cdc.gov/flu/about/season/flu-season.htm. Retrieved 11-22-12.

3. Molinari, Ortega-Sanchez, Messonnier, Thompson, Wortley, Weintraub, Bridges. The annual impact of seasonal influenza in the US: Measuring disease burden and costs doi:10.1016/j.vaccine.2007.03.046 PMID 17544181.

4. Flu Season Overview North Carolina Immunization portal. Retrieved 11-22-12.

5. West NE, Boyle MP, Mogayzel PJ, Riekert KA, Lechtzin N. The ability of home spirometry and symptom monitoring to predict exacerbations in cystic fibrosis. Pediatric Pulmonology 2009; Vol. 34, S32 “Poster Session Abstract” poster 376.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpersonalspirometer/personalspirometry/prweb10431368.htm


Source: prweb



comments powered by Disqus